Skip to main content
HeartCited

Nattokinase 관련 Atherosclerosis

B

12-month RCT showed reduced carotid intima-media thickness progression. Fibrinolytic activity well-documented. Blood pressure reduction also demonstrated.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'heartcited.com'; const params = 'ingredient\u003Dnattokinase\u0026condition\u003Datherosclerosis'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    


    
    

      Widget powered by
      .
      Free, no account required.
    

  




    








    

        

            B

        

        

            
결론

            
            
12-month RCT showed reduced carotid intima-media thickness progression. Fibrinolytic activity well-documented. Blood pressure reduction also demonstrated.

            
            
        

    











    
    

        
        

            

  
Key Statistics





            


    

        
4

        
연구

    

    

        
300

        
참여자

    

    

        
            
            ↑
            
        
        
Positive

    

    

        B

        
등급

    




        


        
        

        
        
        

            

  
Dosage & Usage





            
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units


            
            

                
일반적으로 사용되는 용량

                

                    
                    

                        
general:

                        
2,000 FU (fibrinolytic units)/day

                    

                    
                    

                        
cardiovascularsupport:

                        
2,000-4,000 FU/day

                    

                    
                

                
                

                    상한량: Not formally established; up to 10,800 FU/day used in clinical trials
                

                
            

            

            

            
            

                권장 복용 시간: On empty stomach (between meals) for optimal fibrinolytic activity
            

            
        

        

        
        
        

            

  
Safety & Side Effects





            

                
                

                    
보고된 부작용

                    
    
                        
                        
  • 
                            ⚠
                            Generally well-tolerated
                        
    • 
                        
                        
  • 
                            ⚠
                            Increased bleeding risk (fibrinolytic activity)
                        
    • 
                        
                        
  • 
                            ⚠
                            Mild gastrointestinal discomfort
                        
    • 
                        
                        
  • 
                            ⚠
                            Bruising (rare)
                        
    • 
                        
                    

                

                

                
                

                    
알려진 상호작용

                    
    
                        
                        
  • 
                            ●
                            Anticoagulants — warfarin, DOACs (additive anticoagulant effects — contraindicated)
                        
    • 
                        
                        
  • 
                            ●
                            Antiplatelet drugs (additive bleeding risk)
                        
    • 
                        
                        
  • 
                            ●
                            NSAIDs (increased bleeding risk)
                        
    • 
                        
                        
  • 
                            ●
                            Fish oil at high doses (additive anticoagulant effect)
                        
    • 
                        
                    

                

                

                
                

                    

                        일일 최대 섭취 허용량: Not formally established; up to 10,800 FU/day used in clinical trials
                    

                

                
            

            

                건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.
            

        

        

        
        
        

            

  
Frequently Asked Questions





            




    
    

        
            Does Nattokinase help with Atherosclerosis?
            
        
        

            Based on 4 studies with 300 participants, there is moderate evidence from clinical studies that Nattokinase may support Atherosclerosis management. Our evidence grade is B (Good Evidence).
        

    

    
    

        
            How much Nattokinase should I take for Atherosclerosis?
            
        
        

            Studies have used various dosages. A commonly studied range is 2,000 FU (fibrinolytic units)/day. Always consult your healthcare provider before starting any supplement regimen.
        

    

    
    

        
            Are there side effects of Nattokinase?
            
        
        

            Reported side effects may include Generally well-tolerated, Increased bleeding risk (fibrinolytic activity), Mild gastrointestinal discomfort, Bruising (rare). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
        

    

    
    

        
            How strong is the evidence for Nattokinase and Atherosclerosis?
            
        
        

            We rate the evidence as Grade B (Good Evidence). This rating is based on 4 peer-reviewed studies with 300 total participants. The overall direction of effect is positive.
        

    

    




        

        

        
        
        

            

  
Related Evidence





            

                
                
                

                
                

                    
Nattokinase 다른 건강 상태에 대한 근거

                    

                        
                        
                            High Blood Pressure (Hypertension)
                            C

                        
                        
                    

                

                
            

        

        

    


    
    












    

        FDA 면책 조항:
        이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.